Brompheniramine Maleate is a first-generation H1-receptor antihistamine with significant anticholinergic and sedative properties, widely formulated into OTC cold and allergy combination products. Simson Pharma's Brompheniramine Maleate reference standard and impurities support compendial testing of these high-volume OTC formulations.
Simson Pharma Global Ltd. (UK) and Simson Pharma Global LLC (USA) supply high-quality Brompheniramine Maleate Reference Standards, pharmacopoeial reference materials, and its related impurities to pharmaceutical manufacturers, CROs, analytical laboratories, universities, and regulatory organizations worldwide. To service the Europe and America market efficiently, Simson Pharma Limited has set up Simson Pharma Global Ltd. in United Kingdom and Simson Pharma Global LLC in USA respectively.